追って8月、 聖路加大学研究者がナファモスタットの有害事象の論文を発表 ナファモスタット3日間投与者の1例の脳出血による認知機能障害に言及。投与には注意が必要とした。(原因は不明) 1例で強く牽制か https://t.co/lVVX7T6pAE
Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients https://t.co/Lq9KZDhGYo
This is very important for #myalgicencephalomyelitis #PwME #Fibromyalgia #Lyme, many who take medications that affect the serotonin pathways. I got beginning serotonin syndrome when by drs mixed Cymbalta & Topamax. Advice reading Jalali’s tweets for m
RT @farid__jalali: SEROTONIN SYNDROME being reported more in COVID19 critical illness ... https://t.co/r0OAZNIfN0 @__ice9 @ThinkingCC @ca…
RT @farid__jalali: SEROTONIN SYNDROME being reported more in COVID19 critical illness ... https://t.co/r0OAZNIfN0 @__ice9 @ThinkingCC @ca…
RT @farid__jalali: SEROTONIN SYNDROME being reported more in COVID19 critical illness ... https://t.co/r0OAZNIfN0 @__ice9 @ThinkingCC @ca…
@SmitaKale13 @TFORDCOVID19 @AskDrShashank @ICMRDELHI @ProfBhargava
@exceedhergrasp1 @GemzME
RT @farid__jalali: SEROTONIN SYNDROME being reported more in COVID19 critical illness ... https://t.co/r0OAZNIfN0 @__ice9 @ThinkingCC @ca…
SEROTONIN SYNDROME being reported more in COVID19 critical illness ... https://t.co/r0OAZNIfN0 @__ice9 @ThinkingCC @cameronks @ajaysheshadri @iceman_ex @srrezaie @emcrit @PulmCrit